anti-C5a antibody (EUCODIS)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-C5a antibody (EUCODIS)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor antagonists
TargetsC5a anaphylatoxin chemotactic receptor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEucodis Pharmaceuticals Forschungs und Entwicklungs GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEucodis Pharmaceuticals Forschungs und Entwicklungs GmbH
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A